Physician profile
Adam E Leisy
NPI 1518279470
$148,326.06
in general payments reported to CMS, 2019-2025
10 companies · $314 in 2025
The $314 reported for 2025 was more than what 89% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.89 · 2020: $1,516 · 2021: $31K · 2022: $60K · 2023: $43K · 2024: $12K · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Food and Beverage: $1,545 · Travel and Lodging: $71.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,650.00 |
| Food and Beverage | $1,544.75 |
| Travel and Lodging | $71.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $147,797.00 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $213.96 | 2025 | Bodyguardian |
| Medtronic, INC. | $75.24 | 2025 | Linq II |
| Janssen Pharmaceuticals, INC | $71.79 | 2019-2024 | Xarelto |
| Pfizer INC. | $69.92 | 2019-2024 | |
| Argon Medical Devices, INC. | $25.00 | 2025 | Clot Management |
| E.R. Squibb & Sons, L.L.C. | $24.47 | 2019 | |
| Si-Bone, INC. | $19.14 | 2021 | |
| Csl Behring | $15.94 | 2024 | Kcentra |
| Chiesi USA, INC. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Leisy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.